Providing Training to Improve Diversity and Representation by Duke Clinical Research Institute
Partnering With The CARRA Registry To Design iPERSONAL by Duke Clinical Research Institute
Inviting Our Colleagues To Participate In DCRI On Record by Duke Clinical Research Institute
Sharing Knowledge With Participants & Families Involved In Research by Duke Clinical Research Institute
DCRI’s Medical Communications And Scientific Publishing Group by Duke Clinical Research Institute
Danny Benjamin, MD, PhD, MPH, and Micky Cohen-Wolkowiez, MD, PhD, talk about how the Pediatric Trial Network's research has contributed to the care of infants.
Stanford's Ken Mahaffey, MD, co-founder of DCRI's Clinical Events Classification service, and DCRI's Matt Wilson, RN, discuss the creation of the service.
Assessing Results of Open-label, Comparative Effectiveness Trials for Cardio-metabolic Drugs by Duke Clinical Research Institute
Patient Perspective Nutrition And Diet In Perioperative Recovery by Duke Clinical Research Institute
Data, Innovation & Guidelines in Gastroenterology – Deborah Fisher, MD by Duke Clinical Research Institute
Sunil Rao at TCT 2018: Meeting Highlights and the #RadialFirst Journey by Duke Clinical Research Institute
Renato Lopes at TCT 2018: SECURE-PCI and Timing for Statin Dosing by Duke Clinical Research Institute
Jennifer Rymer at TCT 2018: Aborted TAVR Procedures and Same-Day Discharge for PCI by Duke Clinical Research Institute
The Role of the Dietician in Perioperative Nutrition Screening and Care by Duke Clinical Research Institute
Perioperative Nutrition Optimization Clinics: The Future of Perioperative Care by Duke Clinical Research Institute
What are clinical trials? Who should participate in them? And why are they important? In this episode of Science is the Best Medicine, Abhinav Sharma talks to Harvard’s Eugene Braunwald, MD, a cardiologist who’s been a firsthand witness to more than 50 years of clinical trials.
Duke’s Mona Fiuzat, PhD, talks with Abhinav Sharma about how scientific discoveries are translated to usable treatments and how the U.S. Food and Drug Administration really works.
Cardiologist Joseph Hill, MD, PhD, editor-in-chief of Circulation, discusses what it’s like to run a peer-reviewed journal and how medical discoveries are disseminated in the age of information overload.
Medicare, Obamacare, rising costs, and preexisting conditions: The controversy over health care in the United States rages on in Congress and online. In this episode Mark McClellan, director of the Margolis Center for Health Policy and former U.S. Food and Drug Administration commissioner, discusses the complexities of healthcare policy.
Robert Lefkowitz, MD, won the Nobel Prize for Chemistry in 2012 for his groundbreaking work on the proteins known as receptors. That research has since influenced the development of a wide variety of drugs including antihistamines, ulcer drugs, and beta blockers. In this episode of the podcast, he discusses his research, his family, and the path that brought him to Duke.
Every year, more than two million people in the United States get infections that are resistant to antibiotics and at least 23,000 people die as a result, according to the Centers for Disease Control. These so-called "superbugs" represent one of the major public health threats facing the world today. In this episode, Ephraim Tsalik, MD, PhD, discusses the rise of superbugs and how researchers are trying to find new ways to fight them.
Chronic kidney disease (CKD) is among the most common diseases in the United States, affecting approximately 14 percent of the adult population. The disease, which often goes unnoticed until its advanced stages, can increase the risk of heart attack, stroke, or other serious medical conditions. In this episode of Science is the Best Medicine, Abhinav Sharma, MD, talks with DCRI Co-Chief Fellow John Stanifer, MD, Msc, about his work with CKD research in East Africa and rural North Carolina.